» Authors » K Van Acker

K Van Acker

Explore the profile of K Van Acker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 1154
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Acker K, Garoufalis M, Wilson P
J Wound Care . 2018 Nov; 27(Sup11):1-32. PMID: 30398395
The Point Project is an initiative between the two organisations: D-Foot International and the International Federation of Podiatrists (FIP-IFP). Both organisations promote the role of evidence-based foot care for patients...
2.
Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, et al.
Diabetes Metab Res Rev . 2016 Oct; 33(3). PMID: 27792855
Background: Health-related quality of life (HRQoL) is poor in patients with persistent diabetic foot ulcers and poor HRQoL predicts worse outcomes in these patients. Amputation is often considered a treatment...
3.
Suetens T, Guo M, Van Acker K, Blanpain B
J Hazard Mater . 2015 Feb; 287:180-7. PMID: 25646901
To better understand the phenomena of ZnFe2O4 spinel formation in electric arc furnace dust, the dust was characterized with particle size analysis, X-ray fluorescence (XRF), electron backscatter diffraction (EBSD), and...
4.
Siersma V, Thorsen H, Holstein P, Kars M, Apelqvist J, Jude E, et al.
Diabet Med . 2013 Jun; 30(11):1382-7. PMID: 23758490
Aim: To identify the factors responsible for the low health-related quality of life associated with foot ulcers and the relative importance of these factors. Methods: A total of 1232 patients...
5.
Van Loock M, Hombrouck A, Jacobs T, Winters B, Meersseman G, Van Acker K, et al.
J Virol Methods . 2012 Nov; 187(2):238-47. PMID: 23178583
Early HIV-1 integrase inhibitors, such as compounds containing a β-diketo acid moiety, were identified by extensive high-throughput screening campaigns. Traditionally, in vitro biochemical assays, measuring the catalytic activities of integrase,...
6.
Van Loock M, Meersseman G, Van Acker K, Van Den Eynde C, Jochmans D, Van Schoubroeck B, et al.
J Virol Methods . 2011 Dec; 179(2):396-401. PMID: 22172974
The discovery of HIV-1 integrase inhibitors has been enabled by high-throughput screening and rational design of novel chemotypes. Traditionally, biochemical assays focusing on the strand transfer activity of integrase have...
7.
van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, et al.
Diabet Med . 2011 Jan; 28(2):199-205. PMID: 21219430
Objectives: The incidence of minor amputation may vary significantly, and determinants of minor amputation have not been studied systematically. We evaluated minor amputation rate, the determinants of minor amputation and...
8.
Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, et al.
Diabetes Metab . 2009 Mar; 35(3):206-13. PMID: 19297223
Aims: Diabetic polyneuropathy (DPN) without or with neuropathic pain (DPN-P) is one of the most frequent complications of diabetes. To better delineate their respective prevalences, we conducted a cross-sectional study...
9.
Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al.
Diabetologia . 2008 Jul; 51(10):1826-34. PMID: 18648766
Aims/hypothesis: The aim of the present study was to investigate resource utilisation and associated costs in patients with diabetic foot ulcers and to analyse differences in resource utilisation between individuals...
10.
Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al.
Diabet Med . 2008 Jun; 25(6):700-7. PMID: 18544108
Aims: To determine current management and to identify patient-related factors and barriers that influence management strategies in diabetic foot disease. Methods: The Eurodiale Study is a prospective cohort study of...